PharmaWatch: Immune Disorders & Inflammation: February 2003
Business Insights
February 1, 2003 31 Pages - SKU: RET859166
|
|
|
"Reuters Business Insight’s IDI PharmaWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into what’s happening in the IDI market, tracking the latest R&D innovations while keeping an eye on companies' performance and the regulatory environment.
The IDI PharmaWatch brings you the latest news, opinion and research in the IDI industry. It covers all the major current business issues and events, including R&D, licensing deals, alliances and joint ventures, and regulatory decisions."
|
R&D Update
- Key Announcements
- Arthritis
- Diabetes
- Asthma
- Other Respiratory
- Other IDI
Industry Comment
- Abbott: charity begins at home
- GSK: short term bright, long term gloomy
News Headlines
- Arthritis
- Diabetes
- Asthma
- Other Respiratory
- Other IDI
Company Spotlight
Further Reading
Index
- Pharma companies
- Biotech companies
- Key drugs
Share this report
Other tasks Related Markets Allergy/Immunology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
